Imipramine blue sensitively and selectively targets FLT3-ITD positive acute myeloid leukemia cells
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-017-04796-1.pdf
Reference47 articles.
1. Small, D. Targeting FLT3 for the treatment of leukemia. Semin Hematol 45, S17–21, doi: 10.1053/j.seminhematol.2008.07.007 (2008).
2. Konig, H. & Levis, M. Targeting FLT3 to treat leukemia. Expert opinion on therapeutic targets 19, 37–54, doi: 10.1517/14728222.2014.960843 (2015).
3. Kayser, S. & Levis, M. J. FLT3 tyrosine kinase inhibitors in acute myeloid leukemia: clinical implications and limitations. Leuk Lymphoma 55, 243–255, doi: 10.3109/10428194.2013.800198 (2014).
4. Choudhary, C. et al. Mislocalized activation of oncogenic RTKs switches downstream signaling outcomes. Mol.Cell 36, 326–339 (2009).
5. Chan, P. M. Differential signaling of Flt3 activating mutations in acute myeloid leukemia: a working model. Protein & cell 2, 108–115, doi: 10.1007/s13238-011-1020-7 (2011).
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Intralesional Chemotherapy for Prostate Cancer: In vivo Proof of Principle;Oncology;2023
2. The application of antidepressant drugs in cancer treatment;Biomedicine & Pharmacotherapy;2023-01
3. Drug Repurposing Opportunities in Cancer;Drug Repurposing for Emerging Infectious Diseases and Cancer;2023
4. Deregulated calcium signaling in blood cancer: Underlying mechanisms and therapeutic potential;Frontiers in Oncology;2022-10-18
5. Drug Repurposing Strategies for Non-cancer to Cancer Therapeutics;Anti-Cancer Agents in Medicinal Chemistry;2022-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3